xCELLigence RTCA CardioECR - Cardiomyocyte Contractility & Electrical Activity
RUO
The Agilent xCELLigence RTCA CardioECR instrument combines high frequency measurement of cell-induced electrical impedance with multi-electrode array (MEA) technology to simultaneously assess cardiomyocyte contractility, viability, and electrophysiology. The simultaneous recording of impedance and field potential by the xCELLigence RTCA CardioECR instrument provides a view of cardiomyocyte health at an unprecedented level of detail, enabling a deeper understanding of the mechanisms underlying drug-induced cardiac liability.
The CardioECR can also be used to functionally mature hiPSC cardiomyocytes with its electronic pacing function. Paced hiPSC cardiomyocytes provide significantly improved cell models used in various applications including safety/tox assessment, drug discovery, and cardiac disease research.
The CardioECR can also be used to functionally mature hiPSC cardiomyocytes with its electronic pacing function. Paced hiPSC cardiomyocytes provide significantly improved cell models used in various applications including safety/tox assessment, drug discovery, and cardiac disease research.
For Research Use Only. Not for use in diagnostic procedures.
Download the product brochure using the DOWNLOADS button above, or request more information about the xCELLigence RTCA CardioECR - Cardiomyocyte Contractility & Electrical Activity
Product Details
Features
- Monitor excitation-contraction coupling and integrated ion channel activity
- Generate data that highly correlates with arrhythmogenic activity
- Use the pacing function for more tightly controlled assays
- Obtain a more thorough understanding of drug mechanism of action
How It Works
Applications
